Hypoxic and ischemic disorders of infants and children. Lecture for 38th Meeting of Japanese Society of Child Neurology, Tokyo, Japan, July 1996

Brain and Development

Volumn 19, Issue 4, 1997, Pages 235-239

  Johnston, Michael V ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Excitotoxity; Glutamate; Hypoxia; Ischemia; NMDA

Indexed keywords

CALCIUM ION; EXCITATORY AMINO ACID RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BASAL GANGLION; BIOCHEMISTRY; BRAIN CORTEX; BRAIN DISEASE; BRAIN INJURY; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CEREBRAL PALSY; CHILDHOOD DISEASE; COMA; CRYOANESTHESIA; DISEASE SEVERITY; DOG; ELECTROENCEPHALOGRAM; ENZYME ACTIVATION; GESTATIONAL AGE; HYPOXIA; IMMUNOHISTOCHEMISTRY; JAPAN; MUSCLE HYPOTONIA; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; RAT; RESPIRATION DEPRESSION; REVIEW; SEIZURE; SYMPOSIUM; THIRD TRIMESTER PREGNANCY; WHITE MATTER;

ANIMALS; ANOXIA; BRAIN; BRAIN ISCHEMIA; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; JAPAN;

EID: 0030925192     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(96)00561-X     Document Type: Review

References (50)

1. Volpe JJ. Current concepts of brain injury in the premature infant. Am. J. Roentgenol. 1989; 153:472-477.
2. Oka A, Belliveau MJ, Rosenberg PA, Volpe JJ. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms and prevention. J. Neurosci. 1993; 13: 1441-1453.
3. Barkovich AJ. MR and CT evaluation of profound neonatal and infantile asphyxia. J. Neuroradiol. 1992; 13: 959-972.
4. Choi DW, Rothman SW. The role of glutamate in hypoxic-ischemic central nervous system disorders in infants and children. Adv. Pediatrics 1990; 13: 171-182.
5. Johnston MV, Trescher WH, Taylor GA. Hypoxic and ischemic central nervous system disorders in infants and children. Adv. Pediatrics 1995; 42: 1-45.
6. Vannuccci RC. Experimental biology of cerebral hypoxia-ischemia: relation to perinatal brain damage. Pediatr. Res. 1990; 27: 317-326.
7. McDonald JW, Johnston MV. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. Rev. 1990; 15: 41-70.
8. Ikonomidou C, Mosinger JL, Shahid Salles K. Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to NMDA neurotoxicity. J. Neurosci. 1989; 9: 2809-2828.
9. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 1994; 300: 613-622.
10. Dawson VL, Dawson TM, London E, Snyder SH. Nitric oxide mediates glutamate neurotoxicity in primary neuronal cultures. Proc. Natl. Acad. Sci. USA 1991; 88: 368-371.
11. McDonald JW, Silverstein FS, Johnston MV. MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur. J. Pharm. 1987; 140: 359-361.
12. Hattori H, Marian AM, Schwartz PH. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology 1989; 30: 713-718.
13. Menkes JH, Curran J. Clinical and MR correlates in children with extrapyramidal cerebral palsy. AJNR 1994; 15: 451-457.
14. Kuban KCK, Leviton A. Cerebral palsy. N. Engl. J. Med. 1994; 330: 188-195.
15. Silverstein FS, Naik B, Simpson J. Hypoxia-ischemia stimulates hippocampal glutamate efflux in perinatal rat brain: an in vivo microdialysis study. Ped. Res. 1991; 20: 587-590.
16. Andine P, Sandberg M, Bagenholm M, Lehmann A, Hagberg H, Intra- and extracellular changes of amino acids in the cerebral cortex of neonatal rat during hypoxia-ischemia. Dev. Brain Res. 1991; 64: 115-120.
17. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J. Neurochem. 1984; 42: 1-11.
18. Nakanishi S, Masu M. Molecular diversity of glutamate receptors. Ann. Rev. Biophys. Biomolec. Struc. 1994; 23: 319-348.
19. Collingridge GL, Bliss TV. NMDA receptors: their role in long term potentiation. Trends Neurosci. 1987; 10: 288-293.
20. Novelli A, Reilly JA, Lysko PG, Henneberry RC. Glutamate becomes neurotoxic via NMDA receptor when intracellular energy levels are reduced. Brain Res. 1988; 451: 205-212.
21. Tremblay E, Roison MD, Repressa A, Charriaut-Marlange A, Ben-Ari Y. Transient increased density of NMDA binding sites in developing rat hippocampus. Brain Res. 1988; 461: 393-396.
22. McDonald JW, Johnston MV, Young AB. Differential ontogenic development of three receptors comprising the NMDA receptor/ channel complex in the rat hippocampus. Exp. Neurol. 1990; 110: 237-247.
23. Greenamyre JT, Penney JB, Young AB, Hudson C, Silverstein FS, Johnston MV. Evidence for a transient perinatal glutamatergic innervation of globus pallidus. J. Neurosci. 1986; 7: 1022-1030.
24. Chen CK, Silverstein FS, Fisher SK, Johnston MV. Perinatal hypoxic-ischemic brain injury enhances quisqualic acid-stimulated phosphoinositide turnover. J. Neurochem. 1988; 51: 353-359.
25. Tsumoto T, Hagihara K, Soto H. NMDA receptors in the visual cortex of young kittens are more effective than those of adult cats. Nature 1987; 327: 513-514.
26. Bortolotto ZA, Bashir ZI, Davis CH. A molecular switch activated by metabotropic glutamate receptors regulates induction of long term potentiation. Nature 1994; 368: 740-743.
27. Burgard EC, Hablitz JJ. Developmental changes in NMDA and non-NMDA receptor mediated synaptic potentials in rat neocortex. J. Neurophysiol. 1993; 69: 230-240.
28. Monyer H, Burnashev N, Laurie DJ. Development and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1993; 12: 5629-5640.
29. Trescher WH, McDonald JW, Johnston MV. Quinolinate-induced injury is enhanced in developing rat brain. Dev. Brain Res. 1994; 83: 224-232.
30. Paneth N, Stark RI. Cerebral palsy and mental retardation in relation to indicators of perinatal asphyxia. Am. J. Obstet. Gynecol. 1983; 147: 960-969.
31. Nelson KB, Ellenberg JH. Apgar scores as predictors of chronic neurologic disability. Pediatrics 1981; 68: 36-44.
32. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. Arch Neurol. 1976; 33: 696-705.
33. Levene MI, Grindulis H, Sands C, Moore JR. Comparison of two methods of predicting outcome in perinatal asphyxia. Lancet 1986; 1: 67-68.
34. Williams CE, Gunn AJ, Mallard C, Gluckman PD, Outcome after ischemia in the developing sheep brain: an EEG and histological study. Ann. Neurol. 1992; 31: 14-21.
35. Hagberg H, Thornberg E, Blennow M. Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants; relationship to hypoxic-ischemic encephalopathy. Acta Pediatr. Scand. 1993; 82: 925-929.
36. Riikonen RS, Kero PO, Simell OG. Excitatory amino acids in cerebrospinal fluid in neonatal asphyxia. Pediatr. Neurol. 1992; 8: 37-40.
37. Johnston MV, Ishiwa S. Ischemia and excitotoxins in development. Ment. Retard. Dev. Disabil. 1995; 1: 193-200.
38. Baker AJ, Zornow MH, Grafe MR. Hypothermia prevents ischemia-induced increases in hippocampal glycine concentrations in rabbits. Stroke 1991; 22: 666-673.
39. Busto R, Globus MYT, Dietrich WD. Effect of mild hypothermia on ischemic-induced release of neurotransmitter and free amino acids in rat brain. Stroke 1989; 20: 904-910.
40. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689-695.
41. Beal MF, Hyman BT, Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 1993; 16: 125-131.
42. Curless RG, Katz DA, Perryman RA, Ferrar PL, Gelbaum J, Weiner WJ. Choreoathetosis after surgery for congenital heart disease. J. Pediatr. 1994; 124: 737-739.
43. Newburger JW, Jonas RA, Wernovsky G. A comparison of perioperative neurologic effects of hypothermic circulatory arrest versus low flow cardiopulmonary bypass in infant heart surgery. N. Engl. J. Med. 1993; 329: 1057-1064.
44. Redmond JM, Gillinov AM, Zehr KJ et al. Glutamate excitotoxicity: a mechanism of neurologie injury associated with hypothermic circulatory arrest. J. Thorac. Cardiovasc. Surg. 1994; 107: 776-787.
45. Redmond JM, Zehr KJ, Blue ME et al. AMPA glutamate antagonism reduces neurologic injury after hypothermie circulatory arrest. Ann. Thorac. Surg. 1995; 59: 579-584.
46. Brock MV, Blue ME, Lowenstein CJ et al. Induction of neuronal nitric oxide following hypothermie circulatory arrest. Ann. Thorac. Surg. 1996; 62: 1313-1320.
47. Wasterlain CG, Adams LM, Schwartz PH, I-Tattori H, Sofia RD, Wichmann JK. Posthypoxic treatment with felbamate is neuroprotective in a rat model of hypoxia ischemia. Neurology 1993; 43: 2303-2310.
48. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birth weight infants? Pediatrics 1995; 95: 263-269.
49. Gilland E, Puka-Sundvall M, Andine P. Hypoxic-ischemic injury in the neonatal rat brain: effects of pre- and post-treatment with the glutamate release inhibitor BW1003C87. 83. 1994; 83: 79-84.
50. Perlman JM, Risser R. Can asphyxiated infants at risk for neonatal seizures be rapidly identified by current high-risk markers? Pediatrics 1996; 97: 456-462.